XML 48 R29.htm IDEA: XBRL DOCUMENT v3.8.0.1
Equity (Tables)
3 Months Ended
Mar. 31, 2018
Equity [Abstract]  
Schedule of Share Repurchases
Share repurchases for the three months ended March 31 were as follows: 
(in millions, except average price)
2018
 
2017
Total number of shares purchased 1
5.0

 
1.5

Average price paid per share 2
$
178.11

 
$
129.97

Total cash utilized
$
1,100

 
$
201


1 
The three months ended March 31, 2018 include shares received as part of our accelerated share repurchase agreement described in more detail below.
2 
Average price paid per share information does not include the accelerated share repurchase agreement as discussed in more detail below.
Schedule of Redeemable Noncontrolling Interest
Changes to redeemable noncontrolling interest during the three months ended March 31, 2018 were as follows:
(in millions)
 
Balance as of December 31, 2017
$
1,350

Net income attributable to noncontrolling interest
40

Distributions payable to noncontrolling interest
(28
)
Redemption value adjustment
(12
)
Balance as of March 31, 2018
$
1,350


Schedule of Changes in the Components of Accumulated Other Comprehensive Loss
The following table summarizes the changes in the components of accumulated other comprehensive loss for the three months ended March 31, 2018:
(in millions)
Foreign Currency Translation Adjustment
 
Pension and Postretirement Benefit Plans
 
Unrealized Gain (Loss) on Forward Exchange Contracts
 
Unrealized Gain (Loss) on Investments
 
Accumulated Other Comprehensive Loss
Balance as of December 31, 2017
$
(239
)
 
$
(402
)
 
$
2

 
(10
)
 
$
(649
)
Other comprehensive income before reclassifications
5

 

 
2

 
10

 
17

Reclassifications from accumulated other comprehensive loss to net earnings

 
3

1 

(1
)
2 


 
2

Net other comprehensive income
5

 
3

 
1

 
10

 
19

Balance as of March 31, 2018
$
(234
)
 
$
(399
)
 
$
3

 
$

 
$
(630
)
1 
See Note 6 Employee Benefits for additional details of items reclassed from accumulated other comprehensive loss to net earnings.
2 
See Note 5 Derivative Instruments for additional details of items reclassed from accumulated other comprehensive loss to net earnings.